Functional studies using a hippocampal neuron OGD model, an in vitro manifestation of cerebral ischemia, suggested that the PLGA/JNK3-shRNA nanoparticles could efficiently inhibit OGD-induced JNK3 expression and the subsequent neuronal apoptosis. The gene discussed is MAPK10; the disease is Cerebral ischemia.